Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Dijk

Showing results (521-530 of 535) with videos related to

Pageof 54
Sort By:
Leukemia|October 14, 2016
Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrencesE Waanders, B Scheijen, M C J Jongmans, et al.
Psychiatry Research|August 31, 2017
An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibilityKarin Pos, Iris E de Wit, Floor A van Dijk, et al.
Nature Communications|April 6, 2026
Structural and mechanistic basis for antibody neutralization of the measles fusion proteinDawid S Zyla, Roberta Della Marca, Davide Lacarbonara, et al.
Neuroimage|September 15, 2015
MGH-USC Human Connectome Project datasets with ultra-high b-value diffusion MRIQiuyun Fan, Thomas Witzel, Aapo Nummenmaa, et al.
Science Immunology|February 3, 2022
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipientsCorine H GeurtsvanKessel, Daryl Geers, Katharina S Schmitz, et al.
Iscience|December 12, 2022
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccinationDaryl Geers, Roos S G Sablerolles, Debbie van Baarle, et al.
Nature Communications|May 18, 2024
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boostersLuca M Zaeck, Ngoc H Tan, Wim J R Rietdijk, et al.
The Lancet. Infectious Diseases|April 23, 2023
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trialNgoc H Tan, Daryl Geers, Roos S G Sablerolles, et al.
Science (New York, N.Y.)|July 20, 2021
Accurate prediction of protein structures and interactions using a three-track neural networkMinkyung Baek, Frank DiMaio, Ivan Anishchenko, et al.
Journal of Crohn'S & Colitis|October 20, 2020
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort StudyLauranne A A P Derikx, Marten A Lantinga, Dirk J de Jong, et al.
Pageof 54

Showing results (521-530 of 535) with videos related to

Sort By:
Pageof 54
Leukemia|October 14, 2016
Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrencesE Waanders, B Scheijen, M C J Jongmans, et al.
Psychiatry Research|August 31, 2017
An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibilityKarin Pos, Iris E de Wit, Floor A van Dijk, et al.
Nature Communications|April 6, 2026
Structural and mechanistic basis for antibody neutralization of the measles fusion proteinDawid S Zyla, Roberta Della Marca, Davide Lacarbonara, et al.
Neuroimage|September 15, 2015
MGH-USC Human Connectome Project datasets with ultra-high b-value diffusion MRIQiuyun Fan, Thomas Witzel, Aapo Nummenmaa, et al.
Science Immunology|February 3, 2022
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipientsCorine H GeurtsvanKessel, Daryl Geers, Katharina S Schmitz, et al.
Iscience|December 12, 2022
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccinationDaryl Geers, Roos S G Sablerolles, Debbie van Baarle, et al.
Nature Communications|May 18, 2024
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boostersLuca M Zaeck, Ngoc H Tan, Wim J R Rietdijk, et al.
The Lancet. Infectious Diseases|April 23, 2023
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trialNgoc H Tan, Daryl Geers, Roos S G Sablerolles, et al.
Science (New York, N.Y.)|July 20, 2021
Accurate prediction of protein structures and interactions using a three-track neural networkMinkyung Baek, Frank DiMaio, Ivan Anishchenko, et al.
Journal of Crohn'S & Colitis|October 20, 2020
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort StudyLauranne A A P Derikx, Marten A Lantinga, Dirk J de Jong, et al.
Pageof 54